{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:28:41Z","timestamp":1765758521799,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00417-018-4021-x","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T10:37:13Z","timestamp":1527849433000},"page":"1565-1571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies"],"prefix":"10.1007","volume":"256","author":[{"given":"Marie-Christine","family":"Bruender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansjuergen Thomas","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-7173","authenticated-orcid":false,"given":"Christoph","family":"Ehlken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"4021_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1755-3768.2012.02493.x","volume":"91","author":"RP Finger","year":"2013","unstructured":"Finger RP, Wiedemann P, Blumhagen F et al (2013) Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study\u2014a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany. Acta Ophthalmol 91:540\u2013546. \n                    https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02493.x","journal-title":"Acta Ophthalmol"},{"key":"4021_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","volume":"99","author":"FG Holz","year":"2015","unstructured":"Holz FG, Tadayoni R, Beatty S et al (2015) Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Br J Ophthalmol 99:220\u2013226. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305327","journal-title":"Br J Ophthalmol"},{"key":"4021_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001681","volume-title":"Treatment of neovascular age-related macular degeneration patients with vascular endothelial growth factor inhibitors in everyday practice: identification of health care constraints in Germany-the PONS Study","author":"C Ehlken","year":"2017","unstructured":"Ehlken C, Wilke T, Bauer-Steinhusen U et al (2017) Treatment of neovascular age-related macular degeneration patients with vascular endothelial growth factor inhibitors in everyday practice: identification of health care constraints in Germany-the PONS Study. Retina, Philadelphia, PA. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000001681"},{"key":"4021_CR4","doi-asserted-by":"publisher","first-page":"e0143085","DOI":"10.1371\/journal.pone.0143085","volume":"10","author":"S Markun","year":"2015","unstructured":"Markun S, Dishy A, Neuner-Jehle S et al (2015) The chronic care for wet age related macular degeneration (CHARMED) study: a randomized controlled trial. PLoS One 10:e0143085. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0143085","journal-title":"PLoS One"},{"key":"4021_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1755-3768.2010.02074.x","volume":"90","author":"A Hessellund","year":"2012","unstructured":"Hessellund A, Larsen DA, Bek T (2012) The predictive value of subjective symptoms and clinical signs for the presence of treatment-requiring exudative age-related macular degeneration. Acta Ophthalmol 90:471\u2013475. \n                    https:\/\/doi.org\/10.1111\/j.1755-3768.2010.02074.x","journal-title":"Acta Ophthalmol"},{"key":"4021_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/eye.2011.326","volume":"26","author":"R Mathew","year":"2012","unstructured":"Mathew R, Sivaprasad S (2012) Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration. Eye (Lond) 26:389\u2013393. \n                    https:\/\/doi.org\/10.1038\/eye.2011.326","journal-title":"Eye (Lond)"},{"key":"4021_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamaophthalmol.2015.3684","volume":"133","author":"M Thomas","year":"2015","unstructured":"Thomas M, Wolfson Y, Zayit-Soudry S et al (2015) Qualifying to use a home monitoring device for detection of neovascular age-related macular degeneration. JAMA Ophthalmol 133:1425\u20131430. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2015.3684","journal-title":"JAMA Ophthalmol"},{"key":"4021_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cct.2014.02.003","volume":"37","author":"EY Chew","year":"2014","unstructured":"Chew EY, Clemons TE, Bressler SB et al (2014) Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design\u2014HOME study report number 1. Contemp Clin Trials 37:294\u2013300. \n                    https:\/\/doi.org\/10.1016\/j.cct.2014.02.003","journal-title":"Contemp Clin Trials"},{"key":"4021_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1136\/bjo.2010.201129","volume":"95","author":"R Hoerster","year":"2011","unstructured":"Hoerster R, Muether PS, Hermann MM et al (2011) Subjective and functional deterioration in recurrences of neovascular AMD are often preceded by morphologic changes in optic coherence tomography. Br J Ophthalmol 95:1424\u20131426. \n                    https:\/\/doi.org\/10.1136\/bjo.2010.201129","journal-title":"Br J Ophthalmol"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00417-014-2839-4","volume":"253","author":"M McKibbin","year":"2015","unstructured":"McKibbin M, Baker L, Baxter P et al (2015) The accuracy of home monitoring to detect disease activity during maintenance therapy for neovascular ARMD. Graefes Arch Clin Exp Ophthalmol 253:1479\u20131483. \n                    https:\/\/doi.org\/10.1007\/s00417-014-2839-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4021_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/eye.2014.104","volume":"28","author":"L Faes","year":"2014","unstructured":"Faes L, Bodmer NS, Bachmann LM et al (2014) Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis. Eye (Lond) 28:788\u2013796. \n                    https:\/\/doi.org\/10.1038\/eye.2014.104","journal-title":"Eye (Lond)"},{"key":"4021_CR12","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE et al (2015) STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 351:h5527","journal-title":"BMJ"},{"key":"4021_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00347-009-1964-7","volume":"106","author":"F Ziemssen","year":"2009","unstructured":"Ziemssen F, Wiedemann P, Kampik A et al (2009) Intravitreal injections of medications in Germany. Contract situation and legal conditions. Ophthalmologe 106:465\u2013470. \n                    https:\/\/doi.org\/10.1007\/s00347-009-1964-7","journal-title":"Ophthalmologe"},{"key":"4021_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ophtha.2015.12.001","volume":"123","author":"S Mueller","year":"2016","unstructured":"Mueller S, Agostini H, Ehlken C et al (2016) Patient preferences in the treatment of neovascular age-related macular degeneration: a discrete choice experiment. Ophthalmology 123:876\u2013883. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2015.12.001","journal-title":"Ophthalmology"},{"key":"4021_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ophtha.2016.01.011","volume":"123","author":"M Larsen","year":"2016","unstructured":"Larsen M, Waldstein SM, Boscia F et al (2016) Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study. Ophthalmology 123:1101\u20131111. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.011","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4021-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:50:40Z","timestamp":1559357440000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4021-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (institutional review board (IRB) of the University of Freiburg, Germany, reference number: 413\/14) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}